Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does FOSAPREPITANT DIMEGLUMINE Cause Sciatica? 26 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 26 reports of Sciatica have been filed in association with FOSAPREPITANT DIMEGLUMINE (Fosaprepitant). This represents 2.9% of all adverse event reports for FOSAPREPITANT DIMEGLUMINE.

26
Reports of Sciatica with FOSAPREPITANT DIMEGLUMINE
2.9%
of all FOSAPREPITANT DIMEGLUMINE reports
26
Deaths
25
Hospitalizations

How Dangerous Is Sciatica From FOSAPREPITANT DIMEGLUMINE?

Of the 26 reports, 26 (100.0%) resulted in death, 25 (96.2%) required hospitalization, and 25 (96.2%) were considered life-threatening.

Is Sciatica Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for FOSAPREPITANT DIMEGLUMINE. However, 26 reports have been filed with the FAERS database.

What Other Side Effects Does FOSAPREPITANT DIMEGLUMINE Cause?

Dyspnoea (142) Pyrexia (136) Nausea (130) Infusion related reaction (83) Diarrhoea (80) Vomiting (71) Rash (66) Hypersensitivity (65) Stomatitis (64) Decreased appetite (62)

What Other Drugs Cause Sciatica?

ADALIMUMAB (2,253) METHOTREXATE (1,745) TOCILIZUMAB (1,681) RITUXIMAB (1,671) ABATACEPT (1,621) ETANERCEPT (1,583) INFLIXIMAB (1,449) HYDROXYCHLOROQUINE (1,430) PREGABALIN (1,411) LEFLUNOMIDE (1,394)

Which FOSAPREPITANT DIMEGLUMINE Alternatives Have Lower Sciatica Risk?

FOSAPREPITANT DIMEGLUMINE vs FOSCARBIDOPA\FOSLEVODOPA FOSAPREPITANT DIMEGLUMINE vs FOSCARNET FOSAPREPITANT DIMEGLUMINE vs FOSFOMYCIN FOSAPREPITANT DIMEGLUMINE vs FOSFOMYCIN TROMETHAMINE FOSAPREPITANT DIMEGLUMINE vs FOSINOPRIL

Related Pages

FOSAPREPITANT DIMEGLUMINE Full Profile All Sciatica Reports All Drugs Causing Sciatica FOSAPREPITANT DIMEGLUMINE Demographics